Clinical trial
A Prospective, International, Longitudinal, Observational Disease Registry of Patient-reported Outcomes (PROs) and the Association With Hemophilia A and Its Treatment in Patients With Moderate to Severe Hemophilia A
NCT02396862 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, International, Longitudinal, Observational Disease Registry of Patient-reported Outcomes (PROs) and the Association With Hemophilia A and Its Treatment in Patients With Moderate to Severe Hemophilia A
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 9, 2015
- Completion date
- March 26, 2018
- Enrollment
- 272 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.